Agreement for COVID-19 Testing approved
- Document date
- Sep 20, 2021
- Term
- October 1, 2021 - July 31, 2022
The 30-second brief
Approval of Interlocal Agreement between Aldine Independent School District, the City of Houston and Fulgent Therapeutics LLC Re: COVID-19 Testing from October 1, 2021 - July 31, 2022
Fulgent Therapeutics holds this interlocal agreement contract with Aldine Independent School District. Its other public contracts on record include work for El Monte Union High and Downey Unified.
Term as filed: October 1, 2021 - July 31, 2022.
See who signed off on this contract.
See who signed offFree account · 30-second setup · No credit card
Contract details
- Contract type
- Interlocal Agreement
- Document date
- September 20, 2021
- Term
- October 1, 2021 - July 31, 2022
- Vendor
- Fulgent Therapeutics
- Source document
- aldine-isd-agenda-2021-09-20_ac7.txt (Agenda)
Fulgent Therapeutics's other public contracts
More Aldine Independent School District contracts
Questions about this contract
Who was awarded the interlocal agreement contract by Aldine Independent School District?
Fulgent Therapeutics was awarded this interlocal agreement contract by Aldine Independent School District, as recorded on September 20, 2021.
What type of contract is this?
This is a Interlocal Agreement contract, documented as a agenda record.
Where was this contract approved?
This contract appears in aldine-isd-agenda-2021-09-20_ac7.txt (Agenda), dated September 20, 2021 from Aldine Independent School District. Civic IQ extracts contract records directly from agency meeting documents and solicitations.
What other contracts does Fulgent Therapeutics hold?
Fulgent Therapeutics may hold additional government contracts. View their full contract history, the agencies they serve, and total tracked spend on their Civic IQ vendor profile.
Show 1 more question
What is Aldine Independent School District currently buying?
Explore Aldine Independent School District's vendors, signed contracts, and active RFPs on their Civic IQ agency profile.